Clinical and pathological outcomes of nephrectomy/metastasectomy in patients with metastatic renal cell carcinoma after prior immune checkpoint inhibitor exposure

被引：0
|
作者：
Amaral, Paulo Siqueira
Beckermann, Katy
Hillis, Mikala
Schaffer, Kerry Roe
Ancell, Kristin Kathleen
Lambrecht, Morgan
Kaiser, Elizabeth
Rini, Brian I.
机构：
[1] Vandebilt Univ, Med Ctr, Nashville, TN USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[3] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16515
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Nephrectomy after response to immune checkpoint inhibitors for metastatic renal cell carcinoma (mRCC): A surgical challenge allowing favorable oncological outcomes.
    Pignot, Geraldine
    Thiery-Vuillemin, Antoine
    Walz, Jochen
    Gaillard, Victor
    Lang, Herve
    Balssa, Loic
    Geoffrois, Lionnel
    Albiges, Laurence
    Bensalah, Karim
    Schlurmann, Friederike
    Ladoire, Sylvain
    Bigot, Pierre
    Ingels, Alexandre
    Roubaud, Guilhem
    Cassuto, Ophelie
    Parier, Bastien
    Bernhard, Jean-Christophe
    Borchiellini, Delphine
    Gravis, Gwenaelle
    Barthelemy, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [32] OUTCOMES OF NEPHRECTOMY FOR RENAL CELL CARCINOMA WITH VENOUS THROMBUS FOLLOWING IMMUNE CHECKPOINT INHIBITOR THERAPY: A MULTICENTER COLLABORATIVE STUDY
    Ghoreifi, Alireza
    Gerald, Thomas
    Lee, Randall
    Howard, Jeffrey
    Asghar, Aeen
    Khanna, Abhinav
    Quinn, David
    Gill, Inderbir
    Thompson, R. Houston
    Uzzo, Robert
    Margulis, Vitaly
    Djaladat, Hooman
    JOURNAL OF UROLOGY, 2022, 207 (05): : E169 - E169
  • [33] The effect of tumor downsizing on surgical complexity during nephrectomy after immune checkpoint inhibitors for metastatic renal cell carcinoma
    Pignot, Geraldine
    Margue, Gaelle
    Bigot, Pierre
    Lang, Herve
    Balssa, Loic
    Roubaud, Guilhem
    Borchiellini, Delphine
    Bensalah, Karim
    Schlurmann, Friederike
    Ladoire, Sylvain
    Parier, Bastien
    Bernhard, Jean-Christophe
    Cassuto, Ophelie
    Albiges, Laurence
    Thibault, Constance
    Ingels, Alexandre
    Cherifi, Francois
    Waeckel, Thibaut
    Flippot, Ronan
    Geoffrois, Lionnel
    Walz, Jochen
    Gravis, Gwenaelle
    Barthelemy, Philippe
    WORLD JOURNAL OF UROLOGY, 2025, 43 (01)
  • [34] Nephrectomy after complete response to immune checkpoint inhibitors for metastatic renal cell carcinoma (mRCC): A new surgical challenge?
    Pignot, Geraldine
    Thiery-Vuillemin, Antoine
    Walz, Jochen
    Lang, Herve
    Werle, Pierre
    Balssa, Loic
    Geoffrois, Lionnel
    Leblanc, Louis
    Albiges, Laurence
    Di Nunno, Vincenzo
    Bensalah, Karim
    Ladoire, Sylvain
    Gravis, Gwenaelle
    Barthelemy, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [35] SAFETY AND FEASIBILITY OF NEPHRECTOMY AFTER RECEIPT OF IMMUNE CHECKPOINT INHIBITORS FOR RENAL CELL CARCINOMA
    Singla, Nirmish
    Elias, Roy
    Ghandour, Rashed
    Freifeld, Yuval
    Bowman, Isaac
    Woldu, Solomon
    Gahan, Jeffrey
    Bagrodia, Aditya
    Brugarolas, James
    Hammers, Hans
    Margulis, Vitaly
    JOURNAL OF UROLOGY, 2019, 201 (04): : E71 - E71
  • [36] Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma
    Yu, Jiwoong
    Ahn, Hyeonju
    Han, Kyung Yeon
    Song, Wan
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Park, Se Hoon
    Park, Woong-Yang
    Lee, Ji Hyun
    Kang, Minyong
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2025, 16 (02)
  • [37] Fucosylated pro-haptoglobin predicts clinical response to immune checkpoint inhibitor in metastatic renal cell carcinoma
    Kato, Taigo
    Morishita, Koichi
    Tomiyama, Eisuke
    Fujita, Kazutoshi
    Ishizuya, Yu
    Yamamoto, Yoshiyuki
    Hatano, Koji
    Kawashima, Atsunari
    Miyoshi, Eiji
    Nonomura, Norio
    CANCER SCIENCE, 2024, 115 : 1404 - 1404
  • [38] Does concurrent COX inhibition and immune checkpoint blockade improve clinical outcomes in patients with metastatic renal cell carcinoma (mRCC)?
    Kumar, Premsai
    Zhang, Yumeng
    Li, Jiannong
    Manley, Brandon J.
    Chahoud, Jad
    Spiess, Philippe E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [39] Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens
    Saad, Eddy
    Gebrael, Georges
    Semaan, Karl
    Eid, Marc
    Saliby, Renee Maria
    Labaki, Chris
    Sayegh, Nicolas
    Wells, J. Connor
    Takemura, Kosuke
    Ernst, Matthew Scott
    Lemelin, Audreylie
    Basappa, Naveen S.
    Wood, Lori A.
    Powles, Thomas
    Ernst, D. Scott
    Lalani, Aly-Khan A.
    Agarwal, Neeraj
    Xie, Wanling
    Heng, Daniel Y. C.
    Choueiri, Toni K.
    ONCOLOGIST, 2024, 29 (08): : 699 - 706
  • [40] Computed Tomography Texture Analysis for Predicting Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors
    Park, Hyo Jung
    Qin, Lei
    Bakouny, Ziad
    Krajewski, Katherine M.
    Van Allen, Eliezer M.
    Choueiri, Toni K.
    Shinagare, Atul B.
    ONCOLOGIST, 2022, 27 (05): : 389 - 397
12345